Morphine treatment for Neonatal Abstinence Syndrome: huge dosing variability underscores the need for a better clinical study design.

Authors

Paola Mian
Dick Tibboel
Enno D Wildschut
John N van den Anker, George Washington UniversityFollow
Karel Allegaert

Document Type

Journal Article

Publication Date

3-3-2017

Journal

Minerva Pediatrica

DOI

10.23736/S0026-4946.17.04928-3

APA Citation

Mian, P., Tibboel, D., Wildschut, E., van den Anker, J., & Allegaert, K. (2017). Morphine treatment for Neonatal Abstinence Syndrome: huge dosing variability underscores the need for a better clinical study design.. Minerva Pediatrica, (). http://dx.doi.org/10.23736/S0026-4946.17.04928-3

Peer Reviewed

1